search
Back to results

Atrial Fibrillation Ablation Device Comparison Study

Primary Purpose

Atrial Fibrillation

Status
Withdrawn
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Dry bipolar radiofrequency (RF) clamp
Unipolar microwave antenna
Unipolar cryothermic probe
Irrigated unipolar RF antenna
Irrigated bipolar RF clamp
Hi-intensity focused ultrasound wand
Sponsored by
Maimonides Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Atrial Fibrillation focused on measuring Atrial fibrillation, ablation device comparison, ablation in right atria

Eligibility Criteria

19 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All patients undergoing concomitant cardiac surgery who also have AF.

Exclusion Criteria:

  • Patients undergoing re-do or emergency procedures
  • Females of child-bearing age who are pregnant
  • Age less than 19 and more than 75 years old

Sites / Locations

  • Maimonides Medical Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm Type

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Arm Label

Dry bipolar radiofrequency (RF) clamp

Unipolar microwave antenna

Unipolar cryothermic probe

Irrigated unipolar RF antenna

Irrigated bipolar RF clamp

Hi-intensity focused ultrasound wand

Arm Description

used for ablation during surgical procedure

used for ablation during surgical procedure

used for ablation during surgical procedure

used for ablation during surgical procedure

used for ablation during surgical procedure

used for ablation during surgical procedure

Outcomes

Primary Outcome Measures

Freedom from Atrial fibrillation
No atrial fibrillation noted by standard testing (Spot ECG, history, 24-hour Holter recording, Cardiac MRI or echocardiogram, Brain Natriuretic Peptide (BNP) levels
Rhythm at 12 months
No atrial fibrillation noted by standard testing (Spot ECG, history, 24-hour Holter recording, Cardiac MRI or echocardiogram, BNP levels
Major Adverse Cardiovascular Events (MACEs) at 1 and 3 months
Recording any major adverse cardiovascular events reported

Secondary Outcome Measures

Functional and qualitative improvement in heart failure, ejection fraction, left atrial size, exercise tolerance
Quality of life questionnaire
Rhythm at 3, 6 and 9 months
No atrial fibrillation noted by standard testing (Spot ECG, history, 24-hour Holter recording, Cardiac MRI or echocardiogram, BNP levels
All other adverse events
Any adverse events noted throughout period

Full Information

First Posted
April 25, 2007
Last Updated
August 15, 2018
Sponsor
Maimonides Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00466973
Brief Title
Atrial Fibrillation Ablation Device Comparison Study
Official Title
Randomized Comparison of Ablation Devices Used During Surgery for the Treatment of Atrial Fibrillation
Study Type
Interventional

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Withdrawn
Study Start Date
April 2007 (undefined)
Primary Completion Date
November 20, 2008 (Actual)
Study Completion Date
May 2009 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Maimonides Medical Center

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Atrial fibrillation is an irregular heart rhythm which requires long term anticoagulation to prevent risk of stroke and long term poor outcomes. At the same time one have heart surgery, a small additional procedure can be done to treat atrial fibrillation. Surgeons have a choice of six different devices that he or she can use to treat your atrial fibrillation. It is not known at this point which device is best at treating you, as each device seems to have the same success rate at curing atrial fibrillation. One of the six devices will be selected randomly by card pulled out at the time of enrollment. It is therefore the purpose of this study to compare the devices to each other and to follow up after surgery to determine if any one device is best. This information will be valuable to surgeons and to patients as the treatment for atrial fibrillation develops in the future.
Detailed Description
Surgery has been used as a treatment for atrial fibrillation (AF) for more than 20 years. Although highly successful, it has not been widely adopted because operations designed to cure AF require extensive cutting and suturing of the heart, inflicting a significant risk on the patient. Newer technologies now permit the surgeon to create similar scars on the heart as cutting, but much more quickly and safely than before. Over the last ten years at least six different devices have been developed, each of which can scar the heart: Microwave, radiofrequency, ultrasound, laser and cold are some of them. Although there are many papers in the literature studying these devices, each seems to cure about 80% of patients with very low risk of morbidity and/or mortality. This leaves the surgeon with almost no basis upon which to base his or her selection of a device: Which is the best? Which should be used? Therefore, a comparison study is like this is desperately needed. At the time of the surgery, surgeon who perform the AF treatment, he or she will select one of the six devices mentioned above at randomly assigned earlier, at the time of the enrollment. The device will be used to make scars on your heart exactly as described in the manufacturer's instructions and according to the surgeon's experience. The operation will then be completed per routine. In other words, the only part of the procedure that will be done differently from any other is that the actual device chosen to perform the ablation will vary from one study subject to another. Patients will be followed up upto one year with EKGs, Holter monitors, MRI's, 6 minute walk tests, echocardiograms, blood tests like bNP and quality of life questionnaires.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Atrial Fibrillation
Keywords
Atrial fibrillation, ablation device comparison, ablation in right atria

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Dry bipolar radiofrequency (RF) clamp
Arm Type
Active Comparator
Arm Description
used for ablation during surgical procedure
Arm Title
Unipolar microwave antenna
Arm Type
Active Comparator
Arm Description
used for ablation during surgical procedure
Arm Title
Unipolar cryothermic probe
Arm Type
Active Comparator
Arm Description
used for ablation during surgical procedure
Arm Title
Irrigated unipolar RF antenna
Arm Type
Active Comparator
Arm Description
used for ablation during surgical procedure
Arm Title
Irrigated bipolar RF clamp
Arm Type
Active Comparator
Arm Description
used for ablation during surgical procedure
Arm Title
Hi-intensity focused ultrasound wand
Arm Type
Active Comparator
Arm Description
used for ablation during surgical procedure
Intervention Type
Device
Intervention Name(s)
Dry bipolar radiofrequency (RF) clamp
Other Intervention Name(s)
AtriCure
Intervention Description
Specified device used for ablation during standard surgical procedure
Intervention Type
Device
Intervention Name(s)
Unipolar microwave antenna
Other Intervention Name(s)
Boston Scientific FLEX 10
Intervention Description
Specified device used for ablation during standard surgical procedure
Intervention Type
Device
Intervention Name(s)
Unipolar cryothermic probe
Other Intervention Name(s)
Cryocath SurgiFrost
Intervention Description
Specified device used for ablation during standard surgical procedure
Intervention Type
Device
Intervention Name(s)
Irrigated unipolar RF antenna
Other Intervention Name(s)
ESTECH Cobra Adhere
Intervention Description
Specified device used for ablation during standard surgical procedure
Intervention Type
Device
Intervention Name(s)
Irrigated bipolar RF clamp
Other Intervention Name(s)
Meditronic Cardioblate BP
Intervention Description
Specified device used for ablation during standard surgical procedure
Intervention Type
Device
Intervention Name(s)
Hi-intensity focused ultrasound wand
Other Intervention Name(s)
St. Jude Epicor
Intervention Description
Specified device used for ablation during standard surgical procedure
Primary Outcome Measure Information:
Title
Freedom from Atrial fibrillation
Description
No atrial fibrillation noted by standard testing (Spot ECG, history, 24-hour Holter recording, Cardiac MRI or echocardiogram, Brain Natriuretic Peptide (BNP) levels
Time Frame
3 months after surgery
Title
Rhythm at 12 months
Description
No atrial fibrillation noted by standard testing (Spot ECG, history, 24-hour Holter recording, Cardiac MRI or echocardiogram, BNP levels
Time Frame
12 months after surgery
Title
Major Adverse Cardiovascular Events (MACEs) at 1 and 3 months
Description
Recording any major adverse cardiovascular events reported
Time Frame
1 and 3 months post-surgical procedure
Secondary Outcome Measure Information:
Title
Functional and qualitative improvement in heart failure, ejection fraction, left atrial size, exercise tolerance
Description
Quality of life questionnaire
Time Frame
6 and 12 months post-surgical procedure
Title
Rhythm at 3, 6 and 9 months
Description
No atrial fibrillation noted by standard testing (Spot ECG, history, 24-hour Holter recording, Cardiac MRI or echocardiogram, BNP levels
Time Frame
3, 6 and 9 months post-surgical procedure
Title
All other adverse events
Description
Any adverse events noted throughout period
Time Frame
From surgical procedure through 12 months follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
19 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All patients undergoing concomitant cardiac surgery who also have AF. Exclusion Criteria: Patients undergoing re-do or emergency procedures Females of child-bearing age who are pregnant Age less than 19 and more than 75 years old
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Adam E Saltman, MD
Organizational Affiliation
Director Atrial fibrillation Program, Cardiothoracic Surgeon
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Kamran B Ali, MD
Organizational Affiliation
Cardiology Fellow
Official's Role
Principal Investigator
Facility Information:
Facility Name
Maimonides Medical Center
City
Brooklyn
State/Province
New York
ZIP/Postal Code
11219
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Atrial Fibrillation Ablation Device Comparison Study

We'll reach out to this number within 24 hrs